Literature DB >> 14576320

Intrinsic differences between authentic and cryptic 5' splice sites.

Xavier Roca1, Ravi Sachidanandam, Adrian R Krainer.   

Abstract

Cryptic splice sites are used only when use of a natural splice site is disrupted by mutation. To determine the features that distinguish authentic from cryptic 5' splice sites (5'ss), we systematically analyzed a set of 76 cryptic 5'ss derived from 46 human genes. These cryptic 5'ss have a similar frequency distribution in exons and introns, and are usually located close to the authentic 5'ss. Statistical analysis of the strengths of the 5'ss using the Shapiro and Senapathy matrix revealed that authentic 5'ss have significantly higher score values than cryptic 5'ss, which in turn have higher values than the mutant ones. beta-Globin provides an interesting exception to this rule, so we chose it for detailed experimental analysis in vitro. We found that the sequences of the beta-globin authentic and cryptic 5'ss, but not their surrounding context, determine the correct 5'ss choice, although their respective scores do not reflect this functional difference. Our analysis provides a statistical basis to explain the competitive advantage of authentic over cryptic 5'ss in most cases, and should facilitate the development of tools to reliably predict the effect of disease-associated 5'ss-disrupting mutations at the mRNA level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576320      PMCID: PMC275472          DOI: 10.1093/nar/gkg830

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  103 in total

1.  Construction of a novel database containing aberrant splicing mutations of mammalian genes.

Authors:  K Nakai; H Sakamoto
Journal:  Gene       Date:  1994-04-20       Impact factor: 3.688

2.  Involvement of U6 snRNA in 5' splice site selection.

Authors:  S Kandels-Lewis; B Séraphin
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

3.  Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa.

Authors:  Y Jin; H C Dietz; A Nurden; P F Bray
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

4.  Three new mutations in patients with myophosphorylase deficiency (McArdle disease).

Authors:  S Tsujino; S Shanske; I Nonaka; Y Eto; J R Mendell; G M Fenichel; S DiMauro
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

5.  Characterization of a human alpha 1-antitrypsin null allele involving aberrant mRNA splicing.

Authors:  V E Laubach; W J Ryan; M Brantly
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

6.  A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina).

Authors:  S Tsujino; P Tonin; S Shanske; V Nohria; R M Boustany; D Lewis; Y T Chen; S DiMauro
Journal:  Ann Neurol       Date:  1994-03       Impact factor: 10.422

7.  Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome).

Authors:  S Bunge; C Steglich; C Zuther; M Beck; C P Morris; E Schwinger; A Schinzel; J J Hopwood; A Gal
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

8.  Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young.

Authors:  F Sun; B Knebelmann; M E Pueyo; H Zouali; S Lesage; M Vaxillaire; P Passa; D Cohen; G Velho; C Antignac
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.

Authors:  Z Dominski; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF.

Authors:  I C Eperon; D C Ireland; R A Smith; A Mayeda; A R Krainer
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  59 in total

1.  Analysis of SRrp86-regulated alternative splicing: control of c-Jun and IκBβ activity.

Authors:  Amanda S Solis; James G Patton
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

2.  Determinants of the inherent strength of human 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

3.  Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.

Authors:  Xavier Roca; Andrew J Olson; Atmakuri R Rao; Espen Enerly; Vessela N Kristensen; Anne-Lise Børresen-Dale; Brage S Andresen; Adrian R Krainer; Ravi Sachidanandam
Journal:  Genome Res       Date:  2007-11-21       Impact factor: 9.043

4.  Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Authors:  Zhujun Zhang; Yasuaki Habara; Atsushi Nishiyama; Yoshinobu Oyazato; Mariko Yagi; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-06-20       Impact factor: 3.172

5.  Multifactorial interplay controls the splicing profile of Alu-derived exons.

Authors:  Oren Ram; Schraga Schwartz; Gil Ast
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

6.  U7 snRNA-mediated correction of aberrant splicing caused by activation of cryptic splice sites.

Authors:  Hideki Uchikawa; Katsunori Fujii; Yoichi Kohno; Noriyuki Katsumata; Kazuaki Nagao; Masao Yamada; Toshiyuki Miyashita
Journal:  J Hum Genet       Date:  2007-09-13       Impact factor: 3.172

7.  A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia.

Authors:  Samuel Canizales-Quinteros; Carlos A Aguilar-Salinas; Adriana Huertas-Vázquez; María L Ordóñez-Sánchez; Maribel Rodríguez-Torres; José L Venturas-Gallegos; Laura Riba; Salvador Ramírez-Jimenez; Rocío Salas-Montiel; Giovani Medina-Palacios; Ludivina Robles-Osorio; Angel Miliar-García; Luis Rosales-León; Blanca H Ruiz-Ordaz; Alejandro Zentella-Dehesa; Adrian Ferré-D'Amare; Francisco J Gómez-Pérez; Ma Teresa Tusié-Luna
Journal:  Hum Genet       Date:  2004-11-17       Impact factor: 4.132

8.  Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin-Lowry syndrome.

Authors:  Maria Zeniou; Renata Gattoni; André Hanauer; James Stévenin
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

9.  Evolution of the human gastrokine locus and confounding factors regarding the pseudogenicity of GKN3.

Authors:  Jessica H Geahlen; Carlo Lapid; Kaisa Thorell; Igor Nikolskiy; Won Jae Huh; Edward L Oates; Jochen K M Lennerz; Xiaolin Tian; Victoria G Weis; Shradha S Khurana; Samuel B Lundin; Alan R Templeton; Jason C Mills
Journal:  Physiol Genomics       Date:  2013-05-28       Impact factor: 3.107

10.  Synonymous polymorphisms at splicing regulatory sites are associated with CpGs in neurodegenerative disease-related genes.

Authors:  Maria Karambataki; Andigoni Malousi; Nicos Maglaveras; Sofia Kouidou
Journal:  Neuromolecular Med       Date:  2010-01-14       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.